Viking Therapeutics
VKTX
VKTX
386 hedge funds and large institutions have $4.26B invested in Viking Therapeutics in 2024 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 164 increasing their positions, 102 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
386
Holders Change
+14
Holders Change %
+3.76%
% of All Funds
5.61%
Holding in Top 10
6
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-53.85%
% of All Funds
0.09%
New
91
Increased
164
Reduced
102
Closed
70
Calls
$421M
Puts
$185M
Net Calls
+$237M
Net Calls Change
+$1.78M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$123M |
| 2 |
State Street
Boston,
Massachusetts
|
+$95.2M |
| 3 |
JPMorgan Chase & Co
New York
|
+$64.2M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$59.3M |
| 5 |
D.E. Shaw & Co
New York
|
+$23.8M |
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$294M |
| 2 |
BlackRock
New York
|
-$119M |
| 3 |
DM
Deerfield Management
New York
|
-$38M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$29.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$28.6M |
